Creo Medical Group PLC (AIM:CREO)

Creo Medical Group Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.4	12.4	8.7	3	13.1	43.53
Short-Term Investments	-	-	-	15.5	-	-
Cash & Short-Term Investments	7.4	12.4	8.7	18.5	13.1	43.53
Cash Growth	-63.90%	42.53%	-52.97%	41.22%	-69.91%	-3.45%
Accounts Receivable	8.9	4.7	1.3	7.8	5	3.88
Other Receivables	1.9	1.8	2.4	2.8	5.2	4.88
Receivables	10.8	6.5	3.7	10.6	10.2	8.76
Inventory	1.9	2.5	2.7	8.1	9.3	8.5
Prepaid Expenses	-	0.4	0.4	0.7	1.1	0.37
Other Current Assets	1.7	1.7	40.9	-	-	-
Total Current Assets	21.8	23.5	56.4	37.9	33.7	61.17
Property, Plant & Equipment	3	3.4	5.9	9.1	9.7	8.6
Long-Term Investments	30.4	30.9	2.1	2.1	2.6	1.73
Goodwill	-	-	-	19.1	19.6	18.56
Other Intangible Assets	1.6	0.2	0.3	6.8	7.8	8.33
Long-Term Deferred Tax Assets	-	-	-	1.1	1.5	1.71
Long-Term Deferred Charges	-	1.1	0.2	0.3	0.2	0.36
Other Long-Term Assets	-	-	0.1	0.2	0.1	0.15
Total Assets	56.8	59.1	65	76.6	75.2	100.61

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.7	1	0.9	5.7	4.3	3.54
Accrued Expenses	-	3.7	2.9	-	4.1	5.18
Short-Term Debt	-	-	-	2	3.8	3.32
Current Portion of Long-Term Debt	3.1	2.2	2.2	0.5	1.2	1.39
Current Portion of Leases	-	0.1	0.2	0.6	0.6	0.67
Current Unearned Revenue	-	0.2	0.1	-	-	-
Other Current Liabilities	-	0.1	14.2	1.1	3.4	5.63
Total Current Liabilities	7.8	7.3	20.5	9.9	17.4	19.74
Long-Term Debt	0.8	1.8	1.9	4.4	4.9	3.79
Long-Term Leases	-	-	0.1	0.8	1.2	1.39
Long-Term Deferred Tax Liabilities	-	-	-	1.4	2	1.79
Other Long-Term Liabilities	-	-	0.1	0.3	0.4	0.59
Total Liabilities	8.6	9.1	22.6	16.8	25.9	27.29

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.4	0.4	0.4	0.4	0.2	0.18
Additional Paid-In Capital	196.8	191.9	192	180.9	149.5	149.45
Retained Earnings	-174.6	-167.4	-173.1	-144.4	-122.7	-95.76
Comprehensive Income & Other	25.6	25.1	23.1	22.9	22.3	19.45
Total Common Equity	48.2	50	42.4	59.8	49.3	73.32
Shareholders' Equity	48.2	50	42.4	59.8	49.3	73.32
Total Liabilities & Equity	56.8	59.1	65	76.6	75.2	100.61

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.9	4.1	4.4	8.3	11.7	10.56
Net Cash (Debt)	3.5	8.3	4.3	10.2	1.4	32.98
Net Cash Growth	-78.53%	93.02%	-57.84%	628.57%	-95.75%	0.74%
Net Cash Per Share	0.01	0.02	0.01	0.03	0.01	0.20
Filing Date Shares Outstanding	418.58	412.47	402.15	351.25	181.38	178.1
Total Common Shares Outstanding	418.58	412.47	402.15	351.25	181.38	178.1
Working Capital	14	16.2	35.9	28	16.3	41.43
Book Value Per Share	0.12	0.12	0.11	0.17	0.27	0.41
Tangible Book Value	46.6	49.8	42.1	33.9	21.9	46.42
Tangible Book Value Per Share	0.11	0.12	0.10	0.10	0.12	0.26
Land	-	3.5	4.6	4.6	4.6	4.51
Machinery	-	4.3	4.3	6.8	6	5.11
Construction In Progress	-	-	0.1	0.1	1.4	0.15
Leasehold Improvements	-	0.9	2.3	2.6	0.9	0.74

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 17, 2026

Data Sources Report a data error